Literature DB >> 27824823

PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation.

Wei Zou1, Nidhi Rohatgi1, Timothy Hung-Po Chen2, Joel Schilling3, Yousef Abu-Amer2, Steven L Teitelbaum1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27824823      PMCID： PMC5179330          DOI： 10.1038/nm.4208

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.

Authors:  Kyle S McCommis; Zhouji Chen; Xiaorong Fu; William G McDonald; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Metab       Date:  2015-09-03       Impact factor: 27.287

2.  An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.

Authors:  Tomohiro Fukunaga; Wei Zou; Nidhi Rohatgi; Jerry R Colca; Steven L Teitelbaum
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

3.  Osteoclast progenitors reside in the peroxisome proliferator-activated receptor γ-expressing bone marrow cell population.

Authors:  Wei Wei; Daniel Zeve; Xueqian Wang; Yang Du; Wei Tang; Paul C Dechow; Jonathan M Graff; Yihong Wan
Journal:  Mol Cell Biol       Date:  2011-09-26       Impact factor: 4.272

4.  Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.

Authors:  Zhouji Chen; Patrick A Vigueira; Kari T Chambers; Angela M Hall; Mayurranjan S Mitra; Nathan Qi; William G McDonald; Jerry R Colca; Rolf F Kletzien; Brian N Finck
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

5.  Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.

Authors:  Kazuhiro Maeda; Yasuhiro Kobayashi; Nobuyuki Udagawa; Shunsuke Uehara; Akihiro Ishihara; Toshihide Mizoguchi; Yuichiro Kikuchi; Ichiro Takada; Shigeaki Kato; Shuichi Kani; Michiru Nishita; Keishi Marumo; T John Martin; Yasuhiro Minami; Naoyuki Takahashi
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

6.  ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis.

Authors:  Takashi Izawa; Nidhi Rohatgi; Tomohiro Fukunaga; Qun-Tian Wang; Matthew J Silva; Michael J Gardner; Michael L McDaniel; Nada A Abumrad; Clay F Semenkovich; Steven L Teitelbaum; Wei Zou
Journal:  Cell Rep       Date:  2015-06-04       Impact factor: 9.423

7.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

8.  Organ-specific disease provoked by systemic autoimmunity.

Authors:  V Kouskoff; A S Korganow; V Duchatelle; C Degott; C Benoist; D Mathis
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

9.  PPAR-gamma regulates osteoclastogenesis in mice.

Authors:  Yihong Wan; Ling-Wa Chong; Ronald M Evans
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440

10.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre.

Authors:  Jasper de Boer; Adam Williams; George Skavdis; Nicola Harker; Mark Coles; Mauro Tolaini; Trisha Norton; Keith Williams; Kathleen Roderick; Alexandre J Potocnik; Dimitris Kioussis
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532
View more
  14 in total

Review 1.  Distinct but complementary contributions of PPAR isotypes to energy homeostasis.

Authors:  Vanessa Dubois; Jérôme Eeckhoute; Philippe Lefebvre; Bart Staels
Journal:  J Clin Invest       Date:  2017-04-03       Impact factor: 14.808

2.  ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.

Authors:  Nidhi Rohatgi; Wei Zou; Patrick L Collins; Jonathan R Brestoff; Timothy H Chen; Yousef Abu-Amer; Steven L Teitelbaum
Journal:  Blood Adv       Date:  2018-10-09

3.  Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.

Authors:  Lingxin Zhu; Yi Tang; Xiao-Yan Li; Evan T Keller; Jingwen Yang; Jung-Sun Cho; Tamar Y Feinberg; Stephen J Weiss
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

4.  Reply to "PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation".

Authors:  Ronald M Evans; Yihong Wan
Journal:  Nat Med       Date:  2016-11-08       Impact factor: 53.440

Review 5.  Nuclear receptors in osteoclasts.

Authors:  Seyeon Bae; Steven Zeng; Kyung-Hyun Park-Min
Journal:  Curr Opin Pharmacol       Date:  2020-06-20       Impact factor: 5.547

6.  Bone Marrow Adipose Tissue: The First 40 Years.

Authors:  Beate Lanske; Clifford Rosen
Journal:  J Bone Miner Res       Date:  2017-04-14       Impact factor: 6.741

7.  Senescent preosteoclast secretome promotes metabolic syndrome associated osteoarthritis through cyclooxygenase 2.

Authors:  Weiping Su; Guanqiao Liu; Bahram Mohajer; Jiekang Wang; Alena Shen; Weixin Zhang; Bin Liu; Ali Guermazi; Peisong Gao; Xu Cao; Shadpour Demehri; Mei Wan
Journal:  Elife       Date:  2022-07-26       Impact factor: 8.713

8.  PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss.

Authors:  Sudipta Baroi; Piotr J Czernik; Amit Chougule; Patrick R Griffin; Beata Lecka-Czernik
Journal:  Bone       Date:  2021-03-16       Impact factor: 4.626

9.  Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation.

Authors:  Darin Quach; Narayanan Parameswaran; Laura McCabe; Robert A Britton
Journal:  Bone Rep       Date:  2019-11-02

10.  RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss.

Authors:  Yan Hu; Xiaoqun Li; Xin Zhi; Wei Cong; Biaotong Huang; Huiwen Chen; Yajun Wang; Yinghua Li; Lipeng Wang; Chao Fang; Jiawei Guo; Ying Liu; Jin Cui; Liehu Cao; Weizong Weng; Qirong Zhou; Sicheng Wang; Xiao Chen; Jiacan Su
Journal:  EMBO Rep       Date:  2021-06-13       Impact factor: 9.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.